Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts.

Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM.

Cancer Epidemiol Biomarkers Prev. 2018 May 14. doi: 10.1158/1055-9965.EPI-18-0320. [Epub ahead of print]

PMID:
29760239
2.

Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.

Graff RE, Sanchez A, Tobias DK, Rodríguez D, Barrisford GW, Blute ML, Li Y, Sun Q, Preston MA, Wilson KM, Cho E.

Diabetes Care. 2018 Jul;41(7):1432-1437. doi: 10.2337/dc17-2518. Epub 2018 Apr 20.

PMID:
29678810
3.

Reply.

Graff RE, Mucci LA, Hjelmborg JB.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):298-299. doi: 10.1016/j.cgh.2017.09.018. No abstract available.

PMID:
29389490
4.

Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer.

Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):193-200. doi: 10.1158/1055-9965.EPI-17-0547. Epub 2017 Nov 22.

PMID:
29167279
5.

Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics.

Wu YH, Graff RE, Passarelli MN, Hoffman JD, Ziv E, Hoffmann TJ, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):75-85. doi: 10.1158/1055-9965.EPI-17-0516. Epub 2017 Nov 17.

PMID:
29150481
6.

Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.

Hoffman JD, Graff RE, Emami NC, Tai CG, Passarelli MN, Hu D, Huntsman S, Hadley D, Leong L, Majumdar A, Zaitlen N, Ziv E, Witte JS.

PLoS Genet. 2017 Mar 31;13(3):e1006690. doi: 10.1371/journal.pgen.1006690. eCollection 2017 Mar.

7.

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.

Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, Schaefer C, Risch N, Van Den Eeden SK, Witte JS.

Nat Commun. 2017 Jan 31;8:14248. doi: 10.1038/ncomms14248.

8.

Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer.

Graff RE, Möller S, Passarelli MN, Witte JS, Skytthe A, Christensen K, Tan Q, Adami HO, Czene K, Harris JR, Pukkala E, Kaprio J, Giovannucci EL, Mucci LA, Hjelmborg JB.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1256-1264. doi: 10.1016/j.cgh.2016.12.041. Epub 2017 Jan 24.

PMID:
28130150
9.

Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.

Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.

Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19.

10.

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.

Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.

Br J Cancer. 2016 Apr 12;114(8):939-44. doi: 10.1038/bjc.2016.61. Epub 2016 Mar 17.

11.

Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.

Penney KL, Pettersson A, Shui IM, Graff RE, Kraft P, Lis RT, Sesso HD, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):745-9. doi: 10.1158/1055-9965.EPI-15-1078. Epub 2016 Mar 3.

12.

Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA.

Am J Clin Nutr. 2016 Mar;103(3):851-60. doi: 10.3945/ajcn.115.118703. Epub 2016 Jan 27.

13.

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.

Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH, McIntosh C, Nuttall E, Brandt I, Penney KL, Hartman M, Kraft P, Parmigiani G, Christensen K, Koskenvuo M, Holm NV, Heikkilä K, Pukkala E, Skytthe A, Adami HO, Kaprio J; Nordic Twin Study of Cancer (NorTwinCan) Collaboration.

JAMA. 2016 Jan 5;315(1):68-76. doi: 10.1001/jama.2015.17703. Erratum in: JAMA. 2016 Feb 23;315(8):822.

14.

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL.

J Natl Cancer Inst. 2015 Nov 27;108(2). pii: djv346. doi: 10.1093/jnci/djv346. Print 2016 Feb.

15.

A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS.

Cancer Discov. 2015 Aug;5(8):878-91. doi: 10.1158/2159-8290.CD-15-0315. Epub 2015 Jun 1.

16.

Detecting gene-environment interactions in human birth defects: Study designs and statistical methods.

Tai CG, Graff RE, Liu J, Passarelli MN, Mefford JA, Shaw GM, Hoffmann TJ, Witte JS.

Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):692-702. doi: 10.1002/bdra.23382. Epub 2015 May 23.

17.

Replication and heritability of prostate cancer risk variants: impact of population-specific factors.

Virlogeux V, Graff RE, Hoffmann TJ, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):938-43. doi: 10.1158/1055-9965.EPI-14-1372. Epub 2015 Mar 25.

18.

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.

Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA; Transdisciplinary Prostate Cancer Partnership ToPCaP.

Prostate. 2015 Jun 15;75(9):897-906. doi: 10.1002/pros.22973. Epub 2015 Mar 1.

19.

Mammographic density phenotypes and risk of breast cancer: a meta-analysis.

Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS, Czene K, Eriksson L, Hall P, Hartman M, Warren RM, Hislop G, Chiarelli AM, Hopper JL, Krishnan K, Li J, Li Q, Pagano I, Rosner BA, Wong CS, Scott C, Stone J, Maskarinec G, Boyd NF, van Gils CH, Tamimi RM.

J Natl Cancer Inst. 2014 May 10;106(5). pii: dju078. doi: 10.1093/jnci/dju078. Review.

20.

The heritability of prostate cancer in the Nordic Twin Study of Cancer.

Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami HO, Holm NV, Nuttall E, Hansen S, Hartman M, Czene K, Harris JR, Kaprio J, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2303-10. doi: 10.1158/1055-9965.EPI-13-0568. Epub 2014 May 8.

21.

Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Graff RE, Cho E, Lindström S, Kraft P, Willett WC, Eliassen AH.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):516-24. doi: 10.1158/1055-9965.EPI-13-0907. Epub 2014 Jan 17.

22.

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.

Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA.

J Natl Cancer Inst. 2013 Dec 18;105(24):1881-90. doi: 10.1093/jnci/djt332. Epub 2013 Nov 30.

23.

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.

Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509. doi: 10.1158/1055-9965.EPI-12-0042. Epub 2012 Jun 26.

Supplemental Content

Loading ...
Support Center